[The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry]

Arch Bronconeumol. 1999 Oct;35(9):446-54. doi: 10.1016/s0300-2896(15)30041-7.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • Pneumonectomy
  • Pulmonary Emphysema / congenital*
  • Pulmonary Emphysema / genetics
  • Pulmonary Emphysema / therapy*
  • Registries / statistics & numerical data*
  • Smoking / adverse effects
  • Spain
  • alpha 1-Antitrypsin / therapeutic use
  • alpha 1-Antitrypsin Deficiency / congenital*
  • alpha 1-Antitrypsin Deficiency / genetics
  • alpha 1-Antitrypsin Deficiency / therapy*

Substances

  • alpha 1-Antitrypsin